Close
ACHEMA MIDDLE EAST 2026

Novavax Awarded Department of Defense Contract for COVID-19 Vaccine

Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced that the company has been awarded a contract by the...

Intravacc partners with Wageningen Bioveterinary Research and Utrecht University to develop an intranasal COVID-19 vaccine

Intravacc, one of the world’s leading translational research and development vaccine institutes, with an extensive track record in developing viral and bacterial vaccines, has...

Serialization: Syntegon joins OPEN-SCS Group

Syntegon Technology recently joined the Open Serialization Communication Standard (OPEN-SCS) Group. Joint goals include the fight against pharmaceutical counterfeiting and the establishment of interoperable...

CPhI Worldwide 2020 Implements new ‘Informa AllSecure Standard’

CPhI Worldwide – organised by Informa Markets – will this year be organised in accordance with Informa’s AllSecure health and safety standard in response...

GSK announces intention to produce 1 billion doses of pandemic vaccine adjuvant in 2021 to support multiple COVID-19 vaccine collaborations

GSK confirmed its intention to manufacture 1 billion doses of its pandemic vaccine adjuvant system, in 2021, to support the development of multiple adjuvanted...

FDA approves Roche’s Tecentriq in combination with Avastin for people with the most common form of liver cancer

Roche announced that the US FDA has approved Tecentriq® (atezolizumab) in combination with Avastin® (bevacizumab) for the treatment of people with unresectable or metastatic...

FDA Approves Ticagrelor to Reduce Risk of First Heart Attack, Stroke in Patients with Coronary Artery Disease

AstraZeneca’s Brilinta (ticagrelor) has been approved in the US to reduce the risk of a first heart attack or stroke in high-risk patients with...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...